We are live on
!
Find out more
EARNEST Partners Portfolio holdings
AUM
$24.3B
1-Year Est. Return
34.41%
This Fund
S&P 500
This Quarter
Est. Return
-2.58%
1 Year Est. Return
+34.41%
3 Year Est. Return
+66.51%
5 Year Est. Return
+86.35%
10 Year Est. Return
+426.93%
AUM
$14.9B
AUM Growth
-$125M
(-0.84%)
Cap. Flow
+$602M
Cap. Flow
% of AUM
4.04%
Top 10 Holdings %
Top 10 Hldgs %
16.63%
Holding
1,195
New
6
Increased
170
Reduced
89
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UCB
United Community Banks
UCB
|
+$98.2M |
| 2 |
Flowserve
FLS
|
+$86.8M |
| 3 |
SPR
Spirit AeroSystems
SPR
|
+$82.2M |
| 4 |
CTS Corp
CTS
|
+$70M |
| 5 |
Charles River Laboratories
CRL
|
+$62.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VIVO
Meridian Bioscience Inc
VIVO
|
+$115M |
| 2 |
Monolithic Power Systems
MPWR
|
+$75.3M |
| 3 |
Emergent Biosolutions
EBS
|
+$57.3M |
| 4 |
ON Semiconductor
ON
|
+$28.3M |
| 5 |
Sociedad Química y Minera de Chile
SQM
|
+$20.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.5% |
| 2 | Industrials | 19.89% |
| 3 | Technology | 19.85% |
| 4 | Consumer Discretionary | 10.32% |
| 5 | Healthcare | 9.93% |
Similar funds
JG
SC
CS
AF
EARNEST Partners's Q3 2022 Portfolio in Review
As of Q3 2022, EARNEST Partners held 1,195 positions worth $14.9B, down 0.84% from $15B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
EARNEST Partners deployed $602M of net new capital in Q3 2022, opening 6 new positions and adding to 170 existing holdings. Its largest new stake was CTS Corp: 1,744,320 shares worth $72.7M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Meridian Bioscience Inc, an estimated $115M trimmed.
- EARNEST Partners's largest Q3 2022 buy was CTS Corp: 1,744,320 shares worth $72.7M.
- EARNEST Partners added most to United Community Banks in Q3 2022, an estimated $98.2M increase.
- EARNEST Partners's biggest Q3 2022 reduction was Meridian Bioscience Inc, cutting an estimated $115M.
- EARNEST Partners fully exited Emergent Biosolutions in Q3 2022, selling an estimated $57.3M.
- EARNEST Partners's ten largest holdings make up 17% of its $14.9B portfolio in Q3 2022.
- EARNEST Partners opened 6 new positions and closed 18 in Q3 2022.
- EARNEST Partners's portfolio value fell 0.84% quarter-over-quarter to $14.9B.
Based on EARNEST Partners's 13F filing for Q3 2022, filed 14 Nov 2022.